Capital Bank & Trust CO Gsk PLC Transaction History

Capital Bank & Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $212,948 - $241,753	-5,831 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$34.27 - $40.01 $51,336 - $59,934	-1,498 Reduced 20.44%	5,831 $208,000
Q4 2020 Feb 16, 2021	SELL	$34.07 - $39.94 $9.33 Million - $10.9 Million	-273,892 Reduced 97.39%	7,329 $270,000
Q3 2020 Nov 13, 2020	BUY	$38.11 - $42.99 $184,909 - $208,587	4,852 Added 1.76%	281,221 $10.6 Million
Q2 2020 Aug 14, 2020	BUY	$37.87 - $43.58 $3.37 Million - $3.88 Million	89,087 Added 47.57%	276,369 $11.3 Million
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $5.9 Million - $8.88 Million	181,788 Added 3308.85%	187,282 $7.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	5,494	5,494 $237,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.5B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.